Tortoise Investment Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Tortoise Investment Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,480	Closed	-$148K	–	630
2019 Q4	$148K	Hold	2,480	–	–	0.03%	164
2019 Q3	$70K	Hold	2,480	–	–	0.02%	207
2019 Q2	$94K	Hold	2,480	–	–	0.02%	194
2019 Q1	$97K	Hold	2,480	–	–	0.03%	190
2018 Q4	$53K	Hold	2,480	–	–	0.01%	228
2018 Q3	$98K	Hold	2,480	–	–	0.03%	188
2018 Q2	$95K	Sell	2,480 -1,250	-34%	-$46.3K	0.03%	187
2018 Q1	$112K	Buy	+3,730	New	+$126K	0.03%	174

Tortoise Investment Management's BOLD Position: Q1 2020 in Review

Tortoise Investment Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 2,480 shares — an estimated $148K sold.

Tortoise Investment Management first reported a position in BOLD in Q1 2018 and held it in 8 quarters. The position peaked at $148K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Tortoise Investment Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Tortoise Investment Management sold 2,480 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $148K.
Tortoise Investment Management first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 8 quarters.
Tortoise Investment Management's Audentes Therapeutics, Inc position peaked at $148K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Tortoise Investment Management's 13F filing for Q1 2020, filed 5 May 2020.